News
Viking Therapeutics has multiple promising drugs in its portfolio that could generate billions in future revenue. Approval of VK2735 and VK2809 could lead to a surge in the stock's value.
Sage Therapeutics has faced significant setbacks, losing 90% of its value, but still holds potential with Zurzuvae, the only FDA-approved treatment for postpartum depression. Despite recent ...
Claim your 7-day free trial now. Vera Therapeutics, Inc. VERA said on Wednesday that it had completed full enrollment (431 participants) in the pivotal ORIGIN Phase 3 trial of atacicept in ...
Sage Therapeutics is rated a Strong Buy due to its undervaluation, trading below cash holdings, and potential in its drug pipeline, especially Zuranolone. Biogen's $7.22 per share buyout offer ...
NEW YORK CITY, NY / ACCESS Newswire / April 8, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sage Therapeutics, Inc. ("Sage" or "the ...
7 analysts have shared their evaluations of Voyager Therapeutics VYGR during the recent three months, expressing a mix of bullish and bearish perspectives. The table below provides a concise ...
CHICAGO – Alexia Hudson-Ward, Associate Director of Research, Learning, and Strategic Partnerships at the Massachusetts Institute of Technology (MIT) Libraries, has ...
Following is the text of the prayer offered by President Jeffrey R. Holland, acting president of the Quorum of the Twelve Apostles, to rededicate the Toronto Ontario Temple on Sunday, March 23, 2025.
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
Freezing rain, downed trees leave more than 400,000 without power across Ontario following ice storm
More than 400,000 Hydro One customers across the province are still without power, according to Hydro One. City of Orillia has declared a state of emergency The advisories related to the freezing ...
NASDAQ:SAGE opened at $8.28 on Friday. The company has a 50 day simple moving average of $7.48 and a two-hundred day simple moving average of $6.73. The company has a market cap of $509.06 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results